DarioHealth Corp EBITDA Margin Trend

DarioHealth Corp -- USA Stock  

USD 1.49  0.03  2.05%

This module enables investors to look at DarioHealth Corp various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 2 M, Interest Expense of 2 M or Operating Expenses of 8.1 M, but also many exotic indicators such as Asset Turnover of 0.2659, Current Ratio of 2.58 or Free Cash Flow per Share of 0.63. This module is a perfect complement to use when analyzing DarioHealth Corp Valuation or Volatility. It can also complement various DarioHealth Corp Technical models. Additionally see analysis of DarioHealth Corp Correlation with competitors.
Showing smoothed EBITDA Margin of DarioHealth Corp with missing and latest data points interpolated. Measures the ratio between a company's Earnings Before Interest Taxes and Depreciation Amortization EBITDA and Revenues.
EBITDA Margin  10 Years Trend  
Slightly volatile
 EBITDA Margin 

DarioHealth Corp EBITDA Margin Over Time

2016-12-31 (8.27) 
2017-12-31 (8.27) 
2018-12-31 (9.73) 

Other Fundumenentals


Regression Statistics

Arithmetic Mean (8.38)
Coefficient Of Variation (4.83)
Mean Deviation  0.21
Median (8.27)
Standard Deviation  0.40
Sample Variance  0.16
Range  1.46
R Value (0.46)
Mean Square Error  0.14
R Squared  0.21
Significance  0.11
Slope (0.048118)
Total Sum of Squares  1.97

Currently Trending

Sold over 20 shares of
a day ago ago
Traded for 121.85
Purchased over 500 shares of
a day ago ago
Traded for 5.39
Purchased over 200 shares of
a day ago ago
Traded for 10.61